1. Home
  2. PSTV vs WLGS Comparison

PSTV vs WLGS Comparison

Compare PSTV & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • WLGS
  • Stock Information
  • Founded
  • PSTV 1996
  • WLGS 1981
  • Country
  • PSTV United States
  • WLGS Hong Kong
  • Employees
  • PSTV N/A
  • WLGS N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • WLGS Engineering & Construction
  • Sector
  • PSTV Health Care
  • WLGS Consumer Discretionary
  • Exchange
  • PSTV Nasdaq
  • WLGS Nasdaq
  • Market Cap
  • PSTV 10.4M
  • WLGS 8.5M
  • IPO Year
  • PSTV N/A
  • WLGS 2023
  • Fundamental
  • Price
  • PSTV $1.73
  • WLGS $0.57
  • Analyst Decision
  • PSTV Strong Buy
  • WLGS
  • Analyst Count
  • PSTV 1
  • WLGS 0
  • Target Price
  • PSTV $8.00
  • WLGS N/A
  • AVG Volume (30 Days)
  • PSTV 50.9K
  • WLGS 58.4K
  • Earning Date
  • PSTV 08-12-2024
  • WLGS 08-02-2024
  • Dividend Yield
  • PSTV N/A
  • WLGS N/A
  • EPS Growth
  • PSTV N/A
  • WLGS N/A
  • EPS
  • PSTV N/A
  • WLGS N/A
  • Revenue
  • PSTV $6,084,000.00
  • WLGS $6,825,879.00
  • Revenue This Year
  • PSTV $5.21
  • WLGS N/A
  • Revenue Next Year
  • PSTV N/A
  • WLGS N/A
  • P/E Ratio
  • PSTV N/A
  • WLGS N/A
  • Revenue Growth
  • PSTV 733.42
  • WLGS 65.07
  • 52 Week Low
  • PSTV $0.97
  • WLGS $0.40
  • 52 Week High
  • PSTV $3.21
  • WLGS $1.46
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 46.85
  • WLGS 48.68
  • Support Level
  • PSTV $1.74
  • WLGS $0.52
  • Resistance Level
  • PSTV $2.07
  • WLGS $0.58
  • Average True Range (ATR)
  • PSTV 0.16
  • WLGS 0.04
  • MACD
  • PSTV 0.04
  • WLGS -0.00
  • Stochastic Oscillator
  • PSTV 49.25
  • WLGS 28.92

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About WLGS Wang & Lee Group Inc.

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.

Share on Social Networks: